首页> 外文期刊>World Journal of Surgical Oncology >MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma
【24h】

MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma

机译:MicroRNA-9表达是骨肉瘤患者的预后生物标志物

获取原文
       

摘要

Background The purpose of the present study was to examine the expression levels of microRNA-9 (miR-9) in osteosarcoma tissues and normal bone tissues, and investigate the relationships between miR-9 expression, clinicopathological features and the prognosis of patients with osteosarcoma. Methods The expression levels of miR-9 in osteosarcoma tissues and corresponding non-cancerous tissues were detected using a real-time quantitative assay. Differences in patient survival were determined using the Kaplan–Meier method and a log-rank test. A Cox proportional hazards regression analysis was used for univariate and multivariate analyses of prognostic values. Results Compared to non-cancerous bone tissues, the expression levels of miR-9 in osteosarcoma tissues were significantly elevated ( P Conclusions The findings of our study suggest that increased miR-9 expression has a strong correlation with the aggressive progression of osteosarcoma and its overexpression is a statistically significant risk factor affecting overall survival, suggesting that increased miR-9 expression could be a valuable marker of tumor progression and for prognosis of osteosarcoma.
机译:背景技术本研究的目的是检查骨肉瘤组织和正常骨组织中microRNA-9(miR-9)的表达水平,并探讨miR-9表达,临床病理特征与骨肉瘤患者预后之间的关系。方法采用实时定量检测方法检测骨肉瘤组织及相应的非癌组织中miR-9的表达水平。使用Kaplan-Meier方法和对数秩检验确定患者生存率的差异。 Cox比例风险回归分析用于预测值的单变量和多变量分析。结果与非癌性骨组织相比,骨肉瘤组织中miR-9的表达水平显着升高(P结论)我们的研究结果表明,miR-9表达的增加与骨肉瘤的侵袭性进展及其过度表达密切相关。是影响总体生存的统计学上显着的危险因素,提示增加的miR-9表达可能是肿瘤进展和骨肉瘤预后的重要标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号